Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Gal 3
Most Correlated Studies
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
Most Relevant Literature
- The pleiotropic role of galectin-3 in melanoma progression: Unraveling the enigma.
- Galectin-3 and Autophagy in Renal Acute Tubular Necrosis.
- Redefining Immune Dynamics in Acute Pancreatitis: The Protective Role of Galectin-3 Deletion and Tre…
- The role of galectin-3 in bone homeostasis: A review.
- Glycopolymers Decorated with 3-O-Substituted Thiodigalactosides as Potent Multivalent Inhibitors of …
Most Relevant Clinical Trials
- Characterisation of TIM-3/Gal-9 Immune Checkpoints in Primary Central Nervous System Diffuse Large B…
- Intratumoral Injection Of Alpha-Gal Glycosphingolipids
- Identification of Non-gal, Non-HLA Antigens in Patients Implanted With Xenogenic Material
- An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Stud…
- Diagnostic Values of Galectin-3, Soluble ST2 and BNP in Predicting the Clinical Outcome of ST-Segmen…
